Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.56 |
| ▸ | FAAH | O00519 | 5/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | XBP1 | P17861 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.54 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19089770 | 0.83 | MGLL (0.54) | MGLLFAAHHSP90AA1ALDH1A1LMNA | |
| SCHEMBL638714 | 0.81 | MGLL (0.52) | MGLLFAAHHSP90AA1ALDH1A1LMNA | |
| SCHEMBL8734601 | 0.81 | MGLL (0.52) | MGLLFAAHHSP90AA1ALDH1A1LMNA | |
| SCHEMBL8735944 | 0.78 | MGLL (0.62) | MGLLFAAHHSP90AA1ALDH1A1LMNA | |
| SCHEMBL5599720 | 0.78 | MEN1 (0.31) | MGLLFAAHALDH1A1PKM | |
| SCHEMBL10830333 | 0.77 | ALDH1A1 (0.41) | ALDH1A1LMNAPKM | |
| SCHEMBL7259486 | 0.77 | SMN1; SMN2 (0.44) | MGLLFAAHALDH1A1PKMHPGD | |
| SCHEMBL15483457 | 0.77 | MGLL (0.56) | MGLLFAAHHSP90AA1ALDH1A1LMNA | |
| SCHEMBL13528497 | 0.77 | ALDH1A1 (0.36) | ALDH1A1LMNAMAPK1HTTRAB9A | |
| SCHEMBL20710248 | 0.76 | ACHE (0.40) | MGLLFAAHALDH1A1HPGDGSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107849068-B | Method for preparing polyhedral oligomeric silsesquioxanes | 株式会社LG化学 | 2020-09-11 | — | — | CN | claimed |
| US-10501583-B2 | Method for preparing polyhedral oligomeric silsesquioxane | LG CHEM, LTD. (KR) | 2019-12-10 | — | — | US | claimed |
| US-20180201734-A1 | METHOD FOR PREPARING POLYHEDRAL OLIGOMERIC SILSESQUIOXANE | LG CHEM, LTD. (KR) | 2018-07-19 | — | — | US | claimed |
| US-20130101999-A1 | MULTI-LEG LUMINESCENT NANOPARTICLES, MULTI-LEG LUMINESCENT NANOPARTICLE COMPOUNDS AND VARIOUS APPLICATIONS | NANOAXIS, LLC (US) | 2013-04-25 | — | — | US | claimed |
| US-20130035258-A1 | LUMINESCENT TETRAPODS DOTS AND VARIOUS APPLICATIONS | NANOAXIS, LLC (US) | 2013-02-07 | — | — | US | claimed |
| US-7917298-B1 | Nanocrystal taggants | NANOSYS, INC. (US) | 2011-03-29 | — | — | US | claimed |
| US-20100028402-A1 | NANOPARTICLE-BASED ANTICOAGULANT | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2010-02-04 | — | — | US | claimed |
| WO-2008063157-A2 | A NANOPARTICLE-BASED ANTICOAGULANT | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2008-05-29 | — | — | WO | claimed |
| US-20080032415-A1 | Fluorescence Detection Method | FUJIFILM CORPORATION (JP) | 2008-02-07 | — | — | US | claimed |
| US-6699723-B1 | CAPABLE OF LUMINESCENCE AND/OR ABSORPTION AND/OR SCATTERING OR DIFFRACTION WHEN EXCITED BY A RADIATION OR PARTICLE BEAM;USED FOR ELECTRON MICROSCOPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-03-02 | — | — | US | claimed |
| US-6423551-B1 | CORE WITH SHELL OVERCOATING AND LINKING AGENT FOR AFFINITY MOLECULE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-07-23 | — | — | US | claimed |
| EP-0304701-B1 | Polyalkoxysilyl-terminated polydiorganosiloxanes, methods for their preparation, and room temperature vulcanizable compositions containing them | GEN ELECTRIC (US) | 1994-12-07 | — | — | EP | claimed |
| US-4863992-A | Polyalkoxysilyl-terminated polydiorganosiloxanes, methods for their preparation, and room temperature vulcanizable compositions containing them | GENERAL ELECTRIC COMPANY (US) | 1989-09-05 | — | — | US | claimed |
| EP-0304701-A2 | Polyalkoxysilyl-terminated polydiorganosiloxanes, methods for their preparation, and room temperature vulcanizable compositions containing them | GENERAL ELECTRIC COMPANY (US) | 1989-03-01 | — | — | EP | claimed |
| US-20260142201-A1 | ADHESIVE COMPOSITION FOR FUEL CELL SEALING MEMBERS, MEMBER FOR FUEL CELLS, AND METHOD FOR PRODUCING MEMBER FOR FUEL CELLS | SUMITOMO RIKO COMPANY LIMITED (JP) | 2026-05-21 | — | — | US | disclosed |
| EP-4723253-A1 | ADHESIVE COMPOSITION FOR FUEL CELL SEALING MEMBERS, MEMBER FOR FUEL CELLS, AND METHOD FOR PRODUCING MEMBER FOR FUEL CELLS | Sumitomo Riko Company Limited (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-20260034767-A1 | LAMINATE FOR FUEL CELLS | SUMITOMO RIKO COMPANY LIMITED (JP) | 2026-02-05 | — | — | US | disclosed |
| EP-0466011-A1 | Separation membrane | Tosoh Corporation (JP) | 1992-01-15 | — | — | EP | disclosed |
| US-4863992-A | Polyalkoxysilyl-terminated polydiorganosiloxanes, methods for their preparation, and room temperature vulcanizable compositions containing them | GENERAL ELECTRIC COMPANY (US) | 1989-09-05 | — | — | US | disclosed |
| EP-0304701-A2 | Polyalkoxysilyl-terminated polydiorganosiloxanes, methods for their preparation, and room temperature vulcanizable compositions containing them | GENERAL ELECTRIC COMPANY (US) | 1989-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034767-A1 | LAMINATE FOR FUEL CELLS | MAT2B, EPCAM, ILK | MGLL 320/4885FAAH 1949/4885HSP90AA1 3786/4885 |
| US-20260142201-A1 | ADHESIVE COMPOSITION FOR FUEL CELL SEALING MEMBERS, MEMBER FOR FUEL CELLS, AND METHOD FOR PRODUCING MEMBER FOR FUEL CELLS | EPCAM, CDH1, ILK | MGLL 2616/4885FAAH 1990/4885HSP90AA1 3830/4885 |
| US-20100028402-A1 | NANOPARTICLE-BASED ANTICOAGULANT | SERPINC1, F2, ADAMTS13 | MGLL 3950/4885FAAH 1755/4885HSP90AA1 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.